Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 11, 1999

View Archived Issues

Dusa announces encouraging interim results in bladder cancer clinical trial

Scriptgen and DuPont to collaborate on antibacterial drug discovery

Sibia Neurosciences completes phase I study of SIB-1553A and initiates phase II study

Abgenix and AVI BioPharma to develop human antibody for cancer

Magainin and Genentech enter collaboration for asthma treatment

Physiologically active brain natriuretic peptides disclosed by Daiichi

Eisai prepares novel digalactosylceramide derivatives for multiple indications

Novel cholesterol-lowering agent from Forbes Medi-Tech cleared for U.S. clinical trials

Pentose advances development of Inactine and Papirine compounds

Pursuit of pediatric data for lisinopril will extend Zeneca's U.S. market exclusivity

RPR Gencell evaluates SARP-1 gene for cardiovascular indications under agreement with LXR

Cell Pathways confirms novel mechanism of action of exisulind, CP-461 and related compounds

Noven receives first European marketing approval for dental anesthetic patch

Two major clinical trials support safety and efficacy of TOBI in cystic fibrosis patients

Chinese scientists design potent antihypertensive agents

Novel gamma-lactone antibiotics prepared at Chinese university

Terbutaline by infusion pump evaluated for preventing preterm delivery

Abbott files for marketing approval of novel ICU sedative and analgesic compound

FDA approves new indication, new presentation for atovaquone

Imiquimod 1% cream compared to placebo in first episode of genital herpes

IFN-gamma gene transfer to autologous melanoma tumor cells feasible, but further work needed

Oxford GlycoSciences reports steady progress in OGT-918 development programs

Xoma completes phase II development of hu1124; Genentech will decide future course

Incyte announces new database agreement with P&U

Chinese authorities approve anti-HBV drug for marketing

Applications filed in U.S. and Europe for new osteoporosis drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...